CTIC Price Targets and Analyst Ratings NASDAQ:CTIC
CTIC Forecast. What You Should Know.
CTIC Historical Ratings and Targets
About CTI BioPharma Corp.
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.;... CTIC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.